Our Facility

Technology & standards.

Living cells are not pharmaceuticals. The standards are stricter.

Every protocol is produced in a current Good Manufacturing Practice cleanroom, tested against release specifications, and traceable from donor screening through patient administration.

Our 15,000 sq ft facility in Mines Wellness City is Southeast Asia's largest licensed cell manufacturing lab, operating under NPRA, PIC/S, and cGMP authority.

15K+
Square Feet
Cell manufacturing laboratory under continuous environmental control
100+
Patents
Domestic and international, in stem cell culture and processing
20K+
Clinical Cases
Treated across the affiliated research network
70+
Countries
Supplied with 23C-affiliated technology and research
Regulatory Framework

Six layers of compliance.

No single standard guarantees safety alone. Patients are protected by the overlap.

01
cGMP

Current Good Manufacturing Practice

The same standard applied to pharmaceutical production. Covers facility design, equipment, validation, and quality systems end to end.

02
NPRA

National Pharmaceutical Regulatory Agency

Malaysia's Ministry of Health regulator. 23C operates under the same authority that governs the country's medicine supply.

03
PIC/S

Pharmaceutical Inspection Co-operation Scheme

A network of 56 regulators worldwide, including Japan's MHLW and the European Medicines Agency.

04
ACTD

ASEAN Common Technical Dossier

Harmonised regulatory format across ASEAN. Documentation aligns with regional submission requirements.

05
ISO

ISO 9001 & ISO 17025

ISO 9001 governs organisational quality processes. ISO 17025 governs testing laboratories — essential for credible release-testing.

06
CNAS

China National Accreditation Service

International conformity-assessment standard. Affiliated network includes the first CNAS-accredited adult stem cell lab (2011).

How We Compare

Facility specifications, benchmarked.

Not all cell therapy providers operate at the same quality level.

23C Life Science Centre
Typical Regional Clinic
NPRA authorised as cGTP facility
PIC/S cGMP compliance
Variable
In-house cell manufacturing laboratory
Often outsourced
Every-batch release testing
Variable
End-to-end chain of custody
Inconsistent
24/7 environmental monitoring
Air control classified to Grade A cleanroom
Cross-border regulatory acceptance
Datuk Seri Dr David Mah
Regulatory overlap is defence in depth. Each checkpoint exists because an earlier era of medicine learned a costly lesson.
Datuk Seri Dr David Mah
Advisory Board Member, 23C Life Science Centre

Standards explain how.
A consultation explains why it matters for you.

Visit the facility or discuss your specific protocol with our medical team.

Request a Case Review